GoHealth Net Worth
GoHealth Net Worth Breakdown | GOCO |
GoHealth Net Worth Analysis
GoHealth's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including GoHealth's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of GoHealth's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform GoHealth's net worth analysis. One common approach is to calculate GoHealth's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares GoHealth's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing GoHealth's net worth. This approach calculates the present value of GoHealth's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of GoHealth's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate GoHealth's net worth. This involves comparing GoHealth's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into GoHealth's net worth relative to its peers.
Enterprise Value |
|
To determine if GoHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GoHealth's net worth research are outlined below:
| GoHealth had very high historical volatility over the last 90 days | |
| GoHealth has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 798.89 M. Net Loss for the year was (7.32 M) with profit before overhead, payroll, taxes, and interest of 668.28 M. | |
| GoHealth currently holds about 215.4 M in cash with (21.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 24.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| GoHealth has a frail financial position based on the latest SEC disclosures | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Zhibao Technology and GoHealth Head-To-Head Survey - Defense World |
GoHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GoHealth. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GoHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
GoHealth Target Price Consensus
GoHealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. GoHealth's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most GoHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand GoHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of GoHealth, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGoHealth Target Price Projection
GoHealth's current and average target prices are 12.90 and 19.50, respectively. The current price of GoHealth is the price at which GoHealth is currently trading. On the other hand, GoHealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On GoHealth Target Price
Know GoHealth's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as GoHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GoHealth backward and forwards among themselves. GoHealth's institutional investor refers to the entity that pools money to purchase GoHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-12-31 | 48.4 K | Ancora Advisors Llc | 2024-12-31 | 30.5 K | Ameriprise Financial Inc | 2024-12-31 | 28.8 K | Bridgeway Capital Management, Llc | 2024-12-31 | 23.2 K | Empowered Funds, Llc | 2024-12-31 | 23.2 K | Renaissance Technologies Corp | 2024-12-31 | 22.6 K | Acadian Asset Management Llc | 2024-12-31 | 21.1 K | Jpmorgan Chase & Co | 2024-12-31 | 17.2 K | Goldman Sachs Group Inc | 2024-12-31 | 16.2 K | Centerbridge Partners, L.p. | 2024-12-31 | 4.2 M | Blackrock Inc | 2024-12-31 | 308.3 K |
Follow GoHealth's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 297.95 M.Market Cap |
|
Project GoHealth's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
When accessing GoHealth's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures GoHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GoHealth's profitability and make more informed investment decisions.
Evaluate GoHealth's management efficiency
As of the 17th of March 2025, Return On Tangible Assets is likely to drop to -0.0026. In addition to that, Return On Capital Employed is likely to drop to -0.0064. At this time, GoHealth's Total Assets are very stable compared to the past year. As of the 17th of March 2025, Non Current Assets Total is likely to grow to about 1.3 B, while Net Tangible Assets are likely to drop (220.4 M). GoHealth's management efficiency ratios could be used to measure how well GoHealth manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 45.93 | 43.64 | |
| Tangible Book Value Per Share | 15.62 | 16.40 | |
| Enterprise Value Over EBITDA | 3.57 | 3.39 | |
| Price Book Value Ratio | 0.45 | 0.48 | |
| Enterprise Value Multiple | 3.57 | 3.39 | |
| Price Fair Value | 0.45 | 0.48 | |
| Enterprise Value | 1.2 B | 1.1 B |
GoHealth showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 0.8437 | Revenue | Quarterly Revenue Growth 0.406 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GoHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on GoHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GoHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
GoHealth Corporate Filings
| 6th of March 2025 Other Reports | ViewVerify | |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 4th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 23rd of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
GoHealth Earnings per Share Projection vs Actual
GoHealth Corporate Management
| Michael Kelley | Chief Insights | Profile | |
| Melissa Balsan | Chief Officer | Profile | |
| Michael Hargis | Chief Officer | Profile | |
| Shane Cruz | Chief Officer | Profile | |
| Blair Kessler | Chief Officer | Profile | |
| Jason Schulz | Executive Officer | Profile | |
| Stephen Moffat | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (0.66) | Revenue Per Share | Quarterly Revenue Growth 0.406 | Return On Assets |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.